Predictive biomarkers of invasive carcinoma on excision in patients with a diagnosis of ductal carcinoma in situ of the breast by needle biopsy.
Miki Mori(SHOWA Medical University), Laura van’t Veer(University of California, San Francisco), Yunn‐Yi Chen(University of Vermont), Naoko Matsuda(St. Luke's International Hospital), Karla Kerlikowske(City College of San Francisco), Seigo Nakamura(SHOWA Medical University), Gregor Krings(Cleveland Clinic), Koyu Suzuki(St. Luke's International Hospital), Loretta Chan(University of California, San Francisco), Denise M. Wolf, Thea D. Tlsty(University of California, San Francisco), Jean‐Philippe Coppé(University of California, San Francisco)
Cited by 0
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
|Unknown|2008|4.1k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k